Eagle Pharmaceuticals Inc. – Filings and Transcripts – BamSEC

You must log in to view this page.

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

Late quarterly filing notification for Q3 2024

Late quarterly filing notification for Q2 2024

Late quarterly filing notification for Q1 2024

Late annual filing notification for FY 2023

Late quarterly filing notification for Q3 2023

Prospectuses and Registrations Filter

Securities registration termination

Registration withdrawal request

Updated info for already-effective prospectus

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

J. Goldman & Co LP

Nantahala Capital Management, LLC

Nantahala Capital Partners Limited Partnership

Nantahala Capital Management, LLC

Union Square Park Capital Management, LLC

News Filter

Material Definitive Agreement, Material Modification to Rights of Security Holders, Financial Statements or Exhibits

Change in Certifying Accountant, Financial Statements or Exhibits

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Appoints Christopher Krawtschuk as Chief Financial Officer

Adopts Limited Duration Stockholder Rights Plan

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC